Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy after
carpal tunnel syndrome (CTS). Although many conservative managements of UNE were found, their
effectiveness were often unsatisfied without existed guideline. Recently, the perineural
injection of 5% dextrose wate (D5W) is a novel management for CTS but its effect for UNE is
not obviously as CTS. Hence, it is very important to find another novel injectate for UNE.